Related Experiment Video

Updated: Jun 25, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

Potential role for matrix metalloproteinase-3 in gastric ulcer healing

Makoto Tomita1, Takafumi Ando, Masaaki Minami

  • 1Department of Gastroenterology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan.

Digestion
|February 28, 2009
PubMed
Abstract

Insights

Matrix metalloproteinase-3 (MMP-3) levels were elevated at gastric ulcer sites compared to the antrum in patients with gastric ulcers (GU). This suggests MMP-3 plays a key role in gastric ulcer healing.

Area of Science:

  • Gastroenterology
  • Biochemistry
  • Immunology

Background:

  • Matrix metalloproteinases (MMPs) are crucial for extracellular matrix remodeling and inflammation.
  • Gastric ulcers (GU) involve complex inflammatory processes.
  • Understanding the role of MMPs in GU pathogenesis is essential.

Purpose of the Study:

  • To compare matrix metalloproteinase-3 (MMP-3) levels with tissue inhibitor of metalloproteinases-1 (TIMP-1) and inflammatory cytokines in gastric ulcer (GU) patients.
  • To investigate the correlation between MMP-3 and inflammatory markers in GU.
  • To elucidate the specific role of MMP-3 in gastric ulcer healing.

Main Methods:

  • Enrolled 50 GU patients and 6 functional dyspepsia (FD) patients.
  • Collected gastric antrum and ulcer site mucosal biopsies for culture.
  • Measured levels of MMP-3, TIMP-1, IL-1beta, IL-6, and IL-8 in culture supernatants.

Main Results:

  • All GU patients tested positive for Helicobacter pylori, unlike FD patients.
  • Antral levels of TIMP-1, IL-1beta, IL-6, and IL-8 were significantly higher in GU patients.
  • MMP-3 levels were significantly higher at the GU ulcer site than in the antrum and correlated positively with inflammatory markers.

Conclusions:

  • MMP-3 levels are significantly elevated at the gastric ulcer site.
  • These findings suggest MMP-3 plays a critical role in the healing process of gastric ulcers.
  • MMP-3 may be a potential therapeutic target for gastric ulcer treatment.

More Related Videos

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels07:39

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels

Published on: January 22, 2019

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...